文献速递外周动脉疾病

因外周动脉疾病行大截肢的患者发生重度抑郁症和需要长期抗抑郁药的风险高

Patients undergoing major amputation for peripheral arterial disease are at high risk for developing major depressive disorder and requiring long-term antidepressants.
PubMed 文献 · J Vasc Surg · 2025-03-22

基于TriNetX研究数据库的48,568例因外周动脉疾病行下肢截肢的成人患者,经倾向性评分匹配比较大截肢(膝上/膝下)与小截肢(足趾/足)各14,853例。大截肢组术后6个月和1年重度抑郁症诊断及抗抑郁药处方风险均高于小截肢组,1年死亡率在大截肢组亦更高。作者建议血管外科医生应认识到大截肢患者抑郁高发,并对大截肢患者术后转诊精神科专家保持低阈值。

要点

  • 大截肢组术后6个月重度抑郁症诊断率6.3% vs 小截肢组4.6%(P < .001)。
  • 大截肢组术后1年抗抑郁药处方率28.6% vs 小截肢组18.5%(P < .001)。
  • 大截肢组术后1年死亡率为20.7%,小截肢后转大截肢组为21.5%,单纯小截肢组为10.8%。

核心结论

  • 大截肢和小截肢患者术后重度抑郁症诊断率及抗抑郁药需求均随时间增加。
  • 行大截肢或小截肢后转大截肢的患者较小截肢 alone 更易发生术后重度抑郁症并需要抗抑郁药处方。

研究设计与样本

  • 从TriNetX研究数据库识别48,568例因外周动脉疾病行下肢截肢的成人患者,排除术前抑郁或使用抗抑郁药者。
  • 采用倾向性评分匹配形成大截肢(膝上和膝下截肢)组和小截肢(足趾和足截肢)组,每组各14,853例。
  • 主要结局包括术后重度抑郁症诊断、抗抑郁药处方和死亡率,在6个月和1年时间点分析。

主要发现

  • 6个月时,大截肢组重度抑郁症诊断率6.3% vs 小截肢组4.6%(P < .001),抗抑郁药处方率26.8% vs 15.8%(P < .001)。
  • 1年时,大截肢组 vs 小截肢组重度抑郁症诊断率7.7% vs 6.4%(P < .001),抗抑郁药处方率28.6% vs 18.5%(P < .001),死亡率20.7% vs 12%(P < .001)。
  • 1年死亡率在小截肢组、小截肢后转大截肢组和大截肢组分别为10.8%、21.5%和20.7%。
  • 1年重度抑郁症诊断率在小截肢组、小截肢后转大截肢组和大截肢组分别为5.8%、11.4%和7.7%(P < .001)。
  • 1年抗抑郁药处方率在小截肢组、小截肢后转大截肢组和大截肢组分别为16.9%、32%和28.6%(P < .001)。

临床怎么用

  • 作者认为,血管外科医生应了解大截肢患者抑郁的高发生率,并对大截肢患者术后转诊精神科专家保持低阈值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Amputation is an undesirable outcome of severe peripheral artery disease (PAD), which affects both the mobility and broader lifestyle of the patient. Prior studies have shown that lower extremity amputation is associated with increased risk of developing depression in the postoperative period. However, these studies are primarily single-center studies, confined to specific populations, or do not include analysis over various timepoints. The objective of this study was to assess the association between lower extremity amputation level, level of amputation, and postoperative development of depression. This information will allow vascular surgeons to identify patients who are at a high risk for the development of depression after amputation and make the necessary psychiatric referrals. METHODS: A total of 48,568 adult patients who underwent PAD-related lower extremity amputation were identified from the TriNetX Research database following exclusion of those with preoperative depression or use of antidepressants. Propensity score matching was used to develop comparable major amputation (above- and below-knee amputations) (I) and minor amputation cohorts (toe and foot amputations) (II), yielding two groups each with 14,853 patients. Primary outcomes included postoperative diagnosis of major depressive disorder (MDD), prescription of antidepressants, and mortality. Outcomes were analyzed at 6-month and 1-year timepoints. RESULTS: Analysis at 6 months demonstrated that major amputation was associated with a higher risk of developing MDD (6.3% vs 4.6%; P value < .001) and requiring antidepressants (26.8% vs 15.8%; P value < .001) when compared with minor amputation. At 1 year, the incidence of MDD, antidepressant prescriptions, and mortality was 7.7% vs 6.4% (P < .001), 28.6% vs 18.5% (P < .001), and 20.7% vs 12% (P < .001), respectively. Additionally, the 1-year mortality rate was 10.8% vs 21.5% vs 20.7% for the Minor, Minor Followed by Major, and Major amputation groups, respectively. The incidence of MDD diagnosis and antidepressant prescriptions was 5.8% vs 11.4% vs 7.7% (P < .001) and 16.9% vs 32% vs 28.6% (P < .001), for the Minor, Minor Followed by Major and Major amputation groups, respectively. CONCLUSIONS: The prevalence of MDD and antidepressant medication requirements increases over time in the postoperative period for both major and minor amputees. Patients who underwent major amputations and major amputations after minor amputations were more likely to experience postoperative MDD and require antidepressant prescriptions than patients who underwent minor amputation alone. This suggests that vascular surgeons should understand the high incidence of depression in patients undergoing major amputations and should have a low threshold for referral of major amputees to psychiatric experts in the postoperative period.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Lavanga E, Samaan F, Soucy JW, et al. Patients undergoing major amputation for peripheral arterial disease are at high risk for developing major depressive disorder and requiring long-term antidepressants. J Vasc Surg. 2025. PMID: 40122308. doi:10.1016/j.jvs.2025.03.185

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。